|
| Press Releases |
|
 |
|
| Tuesday, September 6, 2022 |
|
|
Oculis announces publication of Phase 2 data showing topical OCS-01 improves macular thickness and visual acuity in patients with diabetic macular edema |
| Oculis S.A., ('Oculis') a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, announces that the Phase 2 DX-211, a randomized, double blinded, multi-center and vehicle controlled clinical trial assessing the safety and efficacy of topical OCS-01 in patients with Diabetic Macular Edema (DME) (NCT05343156) has been published by the Acta Ophthalmologica journal. more info >> |
|
| Tuesday, August 23, 2022 |
|
|
Oculis announces publication of Phase 2 data showing topical eye drops anti-TNFa agent licaminlimab (OCS-02) relieves persistent ocular discomfort in severe dry eye disease |
| Oculis S.A., ('Oculis') a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, announces that the results of the double blinded more info >> |
|
| Wednesday, June 29, 2022 |
|
|
Oculis Announces First Patient Enrolled in Phase 3 OPTIMIZE Trial of OCS-01 in the Treatment of Inflammation and Pain Following Cataract Surgery |
| Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations more info >> |
|
| Wednesday, March 2, 2022 |
|
|
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics |
| Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, and Accure Therapeutics, a private translational neuroscience R&D company more info >> |
|
| Tuesday, February 8, 2022 |
|
|
Oculis appoints Dr. Bastian Dehmel as Chief Development Officer |
| Oculis S.A. ("Oculis"), a late-stage biopharmaceutical company focused on developing transformative ophthalmic treatments to improve the sight and lives of patients, announces the further strengthening of the Company's executive leadership team with the appointment of Dr. Bastian Dehmel as global Chief Development Officer more info >> |
|
| Wednesday, January 5, 2022 |
|
|
Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China) |
| Oculis S.A. ("Oculis"), a late-stage biopharmaceutical company focused on developing transformative ophthalmic treatments to improve the sight and lives of patients, announces the appointment of Mr. Webb Ding as global Chief Operating Officer and General Manager, China, with effect from February 1, 2022. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Trading Central Launches FIBI: AI-Powered Financial Assistant Live Across Research Tools 
Sept 16, 2025 09:15 HKT/SGT
|
|
|
How Not to Lose the Billion Dollars You Didn't Know You Had - Groundbreaking Guide to Protecting Family Fortunes
Sept 16, 2025 08:30 HKT/SGT
|
|
|
JSR Corporation/Inpria Corporation and Lam Research Enter Cross Licensing and Collaboration Agreement to Advance Semiconductor Manufacturing
Sept 16, 2025 9:00 JST
|
|
|
GMG Announces Graphene Coating Patent Approval and Customer Case Study Successes
Sept 15, 2025 20:09 HKT/SGT
|
|
|
CTF Life+ Initiative Strengthens Company Connections with the Younger Generation
Sept 15, 2025 17:33 HKT/SGT
|
|
|
Focus Graphite and C4V Report Breakthrough Early Results Showing 26% Improvement in LFP Cathode Density Using Lac Knife Cathode Ultima
Sept 15, 2025 17:09 HKT/SGT
|
|
|
HKTDC releases research report on biomedicine, Industry development drives GBA global tech leadership
Sept 15, 2025 15:19 HKT/SGT
|
|
|
Toyota Launches Next-Generation New Mobility e-Palette
Sept 15, 2025 15:33 JST
|
|
|
Announcing the results of the 42nd Hong Kong Watch and Clock Design Competition
Sept 15, 2025 11:27 HKT/SGT
|
|
|
Submarine Networks World 2025 - the annual flagship event for the global subsea industry returns to Singapore in September.
Sept 15, 2025 08:00 HKT/SGT
|
|
|
The University of Osaka D3 Center Commences Operation of New Computing and Data Infrastructure Built by NEC
Sept 12, 2025 15:08 JST
|
|
|
GR Yaris "Aero performance package" Set for Japan Launch
Sept 12, 2025 14:40 JST
|
|
|
Mitsubishi Heavy Industries Achieves Target Performance at Pilot Plant for Bioethanol Membrane Dehydration Systems
Sept 12, 2025 14:19 JST
|
|
|
"New Answers to Dementia" Eisai Releases Concept Movie and New Content on Campaign Website for Dementia Month
Sept 12, 2025 13:20 JST
|
|
|
TANAKA PRECIOUS METAL TECHNOLOGIES Succeeds in Developing High-Performance Palladium Alloy Hydrogen Permeable Membrane Operable in the Low-Temperature Range of 300 degrees C
Sept 12, 2025 11:00 JST
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
